Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment
about
sameAs
Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression.Antidepressant actions of histone deacetylase inhibitors.Pharmacokinetics of fluoxetine in rhesus macaques following multiple routes of administration.A new logical insight and putative mechanism behind fluoxetine-induced amenorrhea, hyperprolactinemia and galactorrhea in a case seriesTeratogenic effects of coadministration of fluoxetine and olanzapine on rat fetusesFluoxetine-induced toxicity results in human placental glutathione S-transferase-π (GST-π) dysfunction.Dose-finding study of fluoxetine and venlafaxine for the treatment of self-injurious and stereotypic behavior in rhesus macaques (Macaca mulatta).
P2860
Q33678656-0722DB85-2459-479A-B187-DA2677575333Q35003394-50EA9B93-8068-4BB5-9E43-52039A59DD7AQ36678655-E8044B03-766A-4B4E-AB2C-01BFEF8E3247Q37343584-DEB47E8E-41CD-4140-8EAC-B45BB049020FQ37556400-20853495-86A0-483B-9E2F-14AA1470227EQ40000787-E66F33C4-AA8F-44AE-A125-D0B2B0538355Q43131165-B358A6D5-0C90-4BB5-83DA-55B91D6C0FCF
P2860
Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment
@ast
Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment
@en
Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment
@nl
type
label
Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment
@ast
Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment
@en
Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment
@nl
prefLabel
Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment
@ast
Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment
@en
Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment
@nl
P2093
P1476
Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment
@en
P2093
Charles M Beasley
David J Brunswick
Frederic M Quitkin
Frederick W Reimherr
Jan Fawcett
Jay D Amsterdam
Jerrold F Rosenbaum
P356
10.1016/S0165-0327(00)00333-5
P407
P577
2002-04-01T00:00:00Z